EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Estrogenic activity in tampon products

Emma S Sutherland, Gihani Manodara, Ashley Gillon, Kelsey L Stevens iD, Alexia Kauff, Alison K Heather iD

Journal of the Endocrine Society · 06.05.2026 · 10 (6)

DOI: 10.1210/jendso/bvag094 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of the Endocrine Society, online erschienen am 17.04.2026. Verfasst von Emma S Sutherland und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Physiology, School of Biomedical Science, University of Otago, Dunedin 9013, New Zealand. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: InsituGen Ltd, Organic Initiative Ltd.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Tampons are widely used menstrual products with prolonged mucosal contact, raising questions about their potential role in exposing females to endocrine-disrupting chemicals (EDCs). This study evaluated estrogenic activity in tampon extracts using a cell-based estrogen receptor reporter bioassay. Synthetic and organic tampons sourced from domestic and international markets were tested for estrogenic bioactivity. Of the 18 brands analyzed, estrogenic activity was detected in nearly half, independent of material type. Comparative chemical analysis of one estrogenic-active brand vs one nonactive brand via high-resolution mass spectrometry tentatively identified various plasticizers, surfactants, and fragrance agents, that were present in higher concentrations in the estrogenic-active brand. The list of chemicals included known EDCs, such as phthalates and alkylphenols, that may be responsible for the observed estrogenic activity. Notably, estrogenic activity varied by brand, suggesting formulation-dependent risk. Although the detected in vitro activity levels were low, the findings demonstrate that compounds capable of activating estrogen receptors can leach from tampons. These results highlight the importance of including endocrine bioactivity assays in tampon safety assessments and suggest that safer formulations are achievable. Further investigation is warranted to assess long-term health implications of low-level EDC exposure from menstrual products.

Schlagwörter

Stichwörter der Autor:innen

cell-based bioassayendocrine-disrupting chemicalsestrogen bioactivitytampons

Autor:innen und Institutionen

  • Department of Physiology, School of Biomedical Science, University of Otago, Dunedin 9013, New Zealand.
  • InsituGen Ltd., Dunedin 9013, New Zealand.
  • Department of Medicine, Otago Medical School, University of Otago, Dunedin 9013, New Zealand.
  • Commercial Research & Development, ALS Food and Environmental NZ, Hamilton 3214, New Zealand.

ORCID-Profile: Kelsey L Stevens, Alison K Heather

Förderung

  • InsituGen Ltd
  • Organic Initiative Ltd

Zitieren

APA

Sutherland, E. S., Manodara, G., Gillon, A., Stevens, K. L., Kauff, A., & Heather, A. K. (2026). Estrogenic activity in tampon products. Journal of the Endocrine Society, 10(6). https://doi.org/10.1210/jendso/bvag094

Vancouver

Sutherland ES, Manodara G, Gillon A, Stevens KL, Kauff A, Heather AK. Estrogenic activity in tampon products. Journal of the Endocrine Society. 2026;10(6). doi:10.1210/jendso/bvag094

BibTeX
@article{Sutherland2026,
  author = {Sutherland, Emma S and Manodara, Gihani and Gillon, Ashley and Stevens, Kelsey L and Kauff, Alexia and Heather, Alison K},
  title = {Estrogenic activity in tampon products},
  journal = {Journal of the Endocrine Society},
  year = {2026},
  volume = {10},
  number = {6},
  doi = {10.1210/jendso/bvag094}
}
Kostenlos starten →